Bundang Cha Women's Hospital Opens Korea's First Habitual Heritage Center...Introduction of autoimmune antibody testing
Jun 16, 2025
Cha Medical University Bundang Cha Women's Hospital (Director Kim Young-tak) officially opened 'habitual miscarriage center' for the first time in Korea for systematic diagnosis and treatment of habitual miscarriage patients.
The center is operated around a multidisciplinary treatment system in which not only obstetrics and gynecology but also rheumatology and endocrinology cooperate.
Habitual miscarriage refers to the case of experiencing a natural miscarriage more than once, and about 20% of infertile women suffer from it. The causes of repeated miscarriages vary, including genetic, anatomical, endocrine, and immunological factors, but half of them are difficult to find a clear cause. In particular, the miscarriage rate of pregnant women through infertility procedures tends to be higher.
Professors at Bundang Cha Women's Hospital's Infertility Center recognized that autoimmune disease antibodies, the main cause of habitual miscarriage, needed a more detailed analysis than now.
Accordingly, a multidisciplinary treatment system was introduced that enables more precise immunological and endocrine evaluations by improving the existing approach.
In addition, it plans to realize precision medical care by conducting the latest antibody biomarker research at the same time as the center for patients with habitual miscarriage of unknown cause.
In April, the autoimmune antibody NeoSelf (anti-β2-glycoprotein I/HLA-DR7), which was selected as an advanced medical technology in Japan, was introduced for the first time in Korea and further research is also conducted. It is expected that the success rate of childbirth will also increase if the test is applied to the patient group with habitual miscarriage even though there are no abnormal findings in the existing habitual miscarriage cause analysis test.
"Repeated miscarriage is a disease that has a combination of various causes, and the combination of multidisciplinary cause analysis and the latest diagnostic technology is essential to effectively solve it," said Kim Hyang-gi, director of the Infertility Center at Bundang Cha Women's Hospital. "We will come up with a more fundamental solution through patient-specific diagnosis and treatment."
A recent overseas study reported a 37.2% improvement in the fertility rate compared to the non-treated group in the 'NeoSelf antibody' treatment group associated with autoimmune diseases. Based on these results, we expect to contribute to improving the fertility rate of infertile patients in Korea by introducing new techniques to diagnose previously unknown immunological causes and expanding treatment targets."
The center is operated around a multidisciplinary treatment system in which not only obstetrics and gynecology but also rheumatology and endocrinology cooperate.
Habitual miscarriage refers to the case of experiencing a natural miscarriage more than once, and about 20% of infertile women suffer from it. The causes of repeated miscarriages vary, including genetic, anatomical, endocrine, and immunological factors, but half of them are difficult to find a clear cause. In particular, the miscarriage rate of pregnant women through infertility procedures tends to be higher.
Professors at Bundang Cha Women's Hospital's Infertility Center recognized that autoimmune disease antibodies, the main cause of habitual miscarriage, needed a more detailed analysis than now.
Accordingly, a multidisciplinary treatment system was introduced that enables more precise immunological and endocrine evaluations by improving the existing approach.
In addition, it plans to realize precision medical care by conducting the latest antibody biomarker research at the same time as the center for patients with habitual miscarriage of unknown cause.
In April, the autoimmune antibody NeoSelf (anti-β2-glycoprotein I/HLA-DR7), which was selected as an advanced medical technology in Japan, was introduced for the first time in Korea and further research is also conducted. It is expected that the success rate of childbirth will also increase if the test is applied to the patient group with habitual miscarriage even though there are no abnormal findings in the existing habitual miscarriage cause analysis test.
"Repeated miscarriage is a disease that has a combination of various causes, and the combination of multidisciplinary cause analysis and the latest diagnostic technology is essential to effectively solve it," said Kim Hyang-gi, director of the Infertility Center at Bundang Cha Women's Hospital. "We will come up with a more fundamental solution through patient-specific diagnosis and treatment."
A recent overseas study reported a 37.2% improvement in the fertility rate compared to the non-treated group in the 'NeoSelf antibody' treatment group associated with autoimmune diseases. Based on these results, we expect to contribute to improving the fertility rate of infertile patients in Korea by introducing new techniques to diagnose previously unknown immunological causes and expanding treatment targets."
|
This article was translated by Naver AI translator.
